First Time Loading...
V

Vor Biopharma Inc
NASDAQ:VOR

Watchlist Manager
Vor Biopharma Inc
NASDAQ:VOR
Watchlist
Price: 1.715 USD -0.29%
Updated: May 1, 2024

Income Statement

Earnings Waterfall
Vor Biopharma Inc

Revenue
0 USD
Operating Expenses
-126m USD
Operating Income
-126m USD
Other Expenses
8.2m USD
Net Income
-117.9m USD

Income Statement
Vor Biopharma Inc

Rotate your device to view
Income Statement
Currency: USD
Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(24)
(32)
(43)
(49)
(60)
(66)
(69)
(78)
(82)
(87)
(93)
(101)
(111)
(123)
(126)
Selling, General & Administrative
(7)
(8)
(12)
(15)
(18)
(20)
(21)
(24)
(25)
(27)
(29)
(30)
(32)
(32)
(32)
Research & Development
(17)
(23)
(32)
(34)
(41)
(46)
(48)
(54)
(56)
(60)
(65)
(71)
(80)
(90)
(94)
Operating Income
(24)
N/A
(32)
-34%
(43)
-37%
(49)
-13%
(60)
-21%
(66)
-11%
(69)
-4%
(78)
-13%
(82)
-4%
(87)
-7%
(93)
-7%
(101)
-8%
(111)
-10%
(123)
-10%
(126)
-3%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
0
0
1
1
3
5
7
8
Pre-Tax Income
(23)
N/A
(32)
-35%
(43)
-37%
(49)
-14%
(60)
-21%
(66)
-11%
(69)
-4%
(78)
-13%
(81)
-4%
(86)
-6%
(92)
-7%
(98)
-6%
(106)
-9%
(116)
-9%
(118)
-2%
Net Income
Income from Continuing Operations
(23)
(32)
(43)
(49)
(60)
(66)
(69)
(78)
(81)
(86)
(92)
(98)
(106)
(116)
(118)
Net Income (Common)
(26)
N/A
(36)
-38%
(49)
-37%
(56)
-13%
(65)
-17%
(70)
-7%
(70)
-1%
(78)
-11%
(81)
-4%
(86)
-6%
(92)
-7%
(98)
-6%
(106)
-9%
(116)
-9%
(118)
-2%
EPS (Diluted)
-0.73
N/A
-1
-37%
-1.38
-38%
-1.51
-9%
-1.76
-17%
-1.88
-7%
-2.1
-12%
-2.1
N/A
-2.18
-4%
-2.27
-4%
-2.33
-3%
-1.47
+37%
-1.58
-7%
-1.7
-8%
-1.75
-3%

See Also

Discover More